Lymfoom geassocieerde studies
Open studies
| Naam | ZUMA-2 cohort 3 |
| Titel | A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-X19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2) |
| Status | Open in AUMC (AMC), EMC & UMCG |
| Medicatie | KTE-X19 |
| Populatie | r/r MCL BTKi-naive (i.e. Ibrutinib, Acalabrutinib) |
| Documenten | Subject eligibility |
| Naam | HD21 |
| Titel | Treatment optimization trial in the first line treatment of adv stage HL: comparison of 4-6 cycles of esc BEACOPP with 4-6 cycles of BrECADD |
| Status | Open |
| Deelnemers | AmsterdamUMC - VUmc - JM Zijlstra MeanderMC – JC Regelink Jeroen Bosch ziekenhuis- H Pruijt ADR ziekenhuis Goes- S Kuipers OLVG A’dam – A. Gerrits WFG Hoorn- C Klerk Haga ziekenhuis- L Bohmer LUMC- H Veelken Anthonius ziekenhuis- M Sohne |
| Documenten | Flow + in- en exclusiecriteria Protocol |